ConductScience.org, home

Paper6402289

Definitive nonsurgical therapy of epithelial malignancies of the anal canal. A report of 12 cases.

Flam MS and 8 others. Cancer, 1983. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Definitive nonsurgical therapy of epithelial malignancies of the anal canal. A report of 12 cases. Papers, record 6402289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6402289

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Definitive nonsurgical therapy of epithelial malignancies of the anal canal. A report of 12 cases.
PubMed
Journal
Cancer
PubMed
Year
1983
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
1.96
iCite
Revised in PubMed
2019-06-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Flam MSM S
2John MM
3Lovalvo LJL J
4Mills RJR J
5Ramalho LDL D
6Prather CC
7Mowry PAP A
8Morgan DRD R
9Lau BPB P

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Anus NeoplasmsMajor topic
Carcinoma, Squamous CellMajor topic
FluorouracilMajor topic
MitomycinsMajor topic
Adult
Aged
Brachytherapy
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Leukocyte Count
Male
Middle Aged
Mitomycin
Neoplasm Recurrence, Local
Platelet Count
Prognosis
Radiotherapy, High-Energy

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
33801992Evolution of the Role of Radiotherapy for Anal Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/33801992PubMed
31288054Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal Cancer.Int J Radiat Oncol Biol Phys2019https://conductscience.org/library/papers/31288054PubMed
25008956Optimal treatment strategies for anal cancer.Curr Treat Options Oncol2014https://conductscience.org/library/papers/25008956PubMed
24558509ACR Appropriateness Criteria®-Anal Cancer.Gastrointest Cancer Res2014https://conductscience.org/library/papers/24558509PubMed
16227631State of the art: gastrointestinal malignancies in the human immunodeficiency virus (HIV) population.Int J Gastrointest Cancer2005https://conductscience.org/library/papers/16227631PubMed
1546901Combined chemoradiation therapy for anal cancer. A report of 56 cases.Ann Surg1992https://conductscience.org/library/papers/1546901PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6402289

GET https://conductscience.org/api/papers/v1/6402289/authors